Why the study?
Randomized trials show anticoagulant prophylaxis effectively prevents VTE in hospitalized medical patients with high risk, but prospective real-world data on prophylactic anticoagulant use were lacking.
Population
2371 unselected acutely ill patients hospitalized in medical wards
Comparison
Pharmacological thromboprophylaxis administration vs no prophylaxis
Design
Multicenter prospective observational study
Follow-up
Median length of hospitalization was 13 ± 12 days
Authors
Loading...
Highlights persistent underuse of VTE prophylaxis in medical wards; leaves open implementation strategies targeting identified high-risk predictors.
In real-world internal medicine wards, only 18.6% of acutely ill patients receive pharmacological thromboprophylaxis, with administration driven by factors such as reduced mobility, active cancer, and previous VTE.
Magna et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: